Tradestie Institutional Equity Comparison Engine
SVRA vs CAPR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SVRA Overall Edge
SVRA Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Savara Inc. (SVRA) driven by superior Valuation, Options & Structure while CAPR counters with relative strength in Momentum & Technical. Fundamentally, SVRA trades at 0.4x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, SVRA sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SVRA
SVRA 0.4x vs CAPR 78.7x Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs -7.9%
Momentum & Technical Winner
CAPR
1Y +3.9% vs +44.3% ยท 52W Pos 13% vs 15%
Options & Structure Winner
SVRA
BREAKDOWN (17th %ile IV) vs CONSOLIDATION (89th %ile IV)
SVRA
NASDAQ
Savara Inc.
Pharmaceutical Preparations
$4.42
-4.63% 1D
Market Cap
$1.1B
1M Return
-0.56%
1Y Return
+3.87%
Forward P/E
0.4x
Unified AI Score
57.7 / 100
HOLD
Tech 42.0
Fund 54.0
Flow 70.0
Mom 54.0
CAPR
NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap
$595.4M
1M Return
+26.23%
1Y Return
+44.29%
Forward P/E
78.7x
Unified AI Score
28.0 / 100
SELL
Tech 50.0
Fund 37.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SVRA +3.87%
CAPR +44.29%
Spread: +42.92 pp (CAPR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SVRA Revenue | CAPR Revenue | SVRA Op. Margin | CAPR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2017 | N/A | $0M | N/A | -482.4% | CAPR |
| FY2018 | N/A | $0M | N/A | -917.0% | CAPR |
| FY2019 | N/A | $0M | N/A | -769.5% | CAPR |
| FY2020 | $0M | $0M | -19182.9% | -4412.6% | CAPR |
| FY2021 | N/A | $0M | N/A | -8549.9% | CAPR |
| FY2022 | N/A | $0M | N/A | -1163.9% | CAPR |
| FY2023 | N/A | $30M | N/A | -95.6% | CAPR |
| FY2024 | N/A | $20M | N/A | -191.1% | CAPR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SVRA | CAPR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $595.4M | Larger Scale | SVRA |
| Trailing P/E Ratio Valuation | 0.4x | 78.7x | Lower Multiple | SVRA |
| Forward P/E Ratio Valuation | 0.4x | 78.7x | Lower Multiple | SVRA |
| Revenue Growth (YoY) Growth | +0.0% | -7.9% | Higher Growth | SVRA |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -151.0% | -100.5% | Higher ROE | CAPR |
| 52-Week Range Position Momentum | 13% ($4โ$7) | 15% ($3โ$40) | Stronger Trend | CAPR |
| Beta / 30D Volatility Risk Regime | 1.48ฮฒ ยท 73% Vol | 1.52ฮฒ ยท 152% Vol | Lower Realized Risk | SVRA |
| Unified Institutional Score Composite Signal | 57.7 / 100 (HOLD) | 28.0 / 100 (SELL) | Higher Composite | SVRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SVRA vs CAPR Buy Guide
SVRA
BREAKDOWN
92d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
CAPR
CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
89th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SVRA nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.